261 related articles for article (PubMed ID: 31337024)
1. Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide.
E M Eid E; S Alanazi A; Koosha S; A Alrasheedy A; Azam F; M Taban I; Khalilullah H; Sadiq Al-Qubaisi M; A Alshawsh M
Molecules; 2019 Jul; 24(14):. PubMed ID: 31337024
[TBL] [Abstract][Full Text] [Related]
2. Increased antitumor activity of tumor-specific peptide modified thymopentin.
Lao X; Li B; Liu M; Chen J; Gao X; Zheng H
Biochimie; 2014 Dec; 107 Pt B():277-85. PubMed ID: 25236717
[TBL] [Abstract][Full Text] [Related]
3. Zerumbone causes Bax- and Bak-mediated apoptosis in human breast cancer cells and inhibits orthotopic xenograft growth in vivo.
Sehrawat A; Arlotti JA; Murakami A; Singh SV
Breast Cancer Res Treat; 2012 Nov; 136(2):429-41. PubMed ID: 23053663
[TBL] [Abstract][Full Text] [Related]
4. DFF40-iRGD, a novel chimeric protein with efficient cytotoxic and apoptotic effects against triple-negative breast cancer cells.
Amrollahi-Nia R; Akbari V; Shafiee F
Biotechnol Lett; 2021 Oct; 43(10):1967-1976. PubMed ID: 34482510
[TBL] [Abstract][Full Text] [Related]
5. Zerumbone, a Sesquiterpene, Controls Proliferation and Induces Cell Cycle Arrest in Human Laryngeal Carcinoma Cell Line Hep-2.
Jegannathan SD; Arul S; Dayalan H
Nutr Cancer; 2016 Jul; 68(5):865-72. PubMed ID: 27045964
[TBL] [Abstract][Full Text] [Related]
6. A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects.
Lao X; Li B; Liu M; Shen C; Yu T; Gao X; Zheng H
Apoptosis; 2015 Oct; 20(10):1307-20. PubMed ID: 26283169
[TBL] [Abstract][Full Text] [Related]
7. Zerumbone binding to estrogen receptors: an in-silico investigation.
Eid EEM; Azam F; Hassan M; Taban IM; Halim MA
J Recept Signal Transduct Res; 2018 Aug; 38(4):342-351. PubMed ID: 30396310
[TBL] [Abstract][Full Text] [Related]
8. Notch2 activation is protective against anticancer effects of zerumbone in human breast cancer cells.
Sehrawat A; Sakao K; Singh SV
Breast Cancer Res Treat; 2014 Aug; 146(3):543-55. PubMed ID: 25038880
[TBL] [Abstract][Full Text] [Related]
9. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
10. Zerumbone modulates CD1d expression and lipid antigen presentation pathway in breast cancer cells.
Shyanti RK; Sehrawat A; Singh SV; Mishra JPN; Singh RP
Toxicol In Vitro; 2017 Oct; 44():74-84. PubMed ID: 28633979
[TBL] [Abstract][Full Text] [Related]
11. Zerumbone induces apoptosis in T-acute lymphoblastic leukemia cells.
Abdelwahab SI; Abdul AB; Mohan S; Taha MM; Syam S; Ibrahim MY; Mariod AA
Leuk Res; 2011 Feb; 35(2):268-71. PubMed ID: 20708800
[TBL] [Abstract][Full Text] [Related]
12. β-Glucuronidase triggers extracellular MMAE release from an integrin-targeted conjugate.
López Rivas P; Müller C; Breunig C; Hechler T; Pahl A; Arosio D; Belvisi L; Pignataro L; Dal Corso A; Gennari C
Org Biomol Chem; 2019 May; 17(19):4705-4710. PubMed ID: 31020985
[TBL] [Abstract][Full Text] [Related]
13. In vitro ultramorphological assessment of apoptosis induced by zerumbone on (HeLa).
Abdel Wahab SI; Abdul AB; Alzubairi AS; Mohamed Elhassan M; Mohan S
J Biomed Biotechnol; 2009; 2009():769568. PubMed ID: 19343171
[TBL] [Abstract][Full Text] [Related]
14. A tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1.
Lao X; Liu M; Chen J; Zheng H
PLoS One; 2013; 8(8):e72242. PubMed ID: 23977262
[TBL] [Abstract][Full Text] [Related]
15. Does ligand-receptor mediated competitive effect or penetrating effect of iRGD peptide when co-administration with iRGD-modified SSL?
Zhang WQ; Yu KF; Zhong T; Luo LM; Du R; Ren W; Huang D; Song P; Li D; Zhao Y; Wang C; Zhang X
J Drug Target; 2015 Dec; 23(10):897-909. PubMed ID: 26087869
[TBL] [Abstract][Full Text] [Related]
16. Zerumbone Sensitizes the Anti-Cancer Efficacy of Cisplatin in Hepatocellular Carcinoma Cells.
Jegannathan SD; Arul S; Dayalan H
Anticancer Agents Med Chem; 2022 Aug; 22(16):2885-2895. PubMed ID: 35331096
[TBL] [Abstract][Full Text] [Related]
17. iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice.
Qifan W; Fen N; Ying X; Xinwei F; Jun D; Ge Z
Tumour Biol; 2016 Aug; 37(8):10643-52. PubMed ID: 26867766
[TBL] [Abstract][Full Text] [Related]
18. Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability.
Hu C; Chen X; Huang Y; Chen Y
Sci Rep; 2018 Feb; 8(1):2274. PubMed ID: 29396568
[TBL] [Abstract][Full Text] [Related]
19. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
[TBL] [Abstract][Full Text] [Related]
20. Antileukemic effect of zerumbone-loaded nanostructured lipid carrier in WEHI-3B cell-induced murine leukemia model.
Rahman HS; Rasedee A; How CW; Zeenathul NA; Chartrand MS; Yeap SK; Abdul AB; Tan SW; Othman HH; Ajdari Z; Namvar F; Arulselvan P; Fakurazi S; Mehrbod P; Daneshvar N; Begum H
Int J Nanomedicine; 2015; 10():1649-66. PubMed ID: 25767386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]